Form 8-K - Current report:
SEC Accession No. 0001140361-24-029588
Filing Date
2024-06-10
Accepted
2024-06-10 16:33:55
Documents
13
Period of Report
2024-06-06
Items
Item 5.07: Submission of Matters to a Vote of Security Holders
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K ef20030961_8k.htm   iXBRL 8-K 40566
  Complete submission text file 0001140361-24-029588.txt   175891

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA ions-20240606.xsd EX-101.SCH 3874
3 XBRL TAXONOMY EXTENSION LABEL LINKBASE ions-20240606_lab.xml EX-101.LAB 21966
4 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE ions-20240606_pre.xml EX-101.PRE 16050
16 EXTRACTED XBRL INSTANCE DOCUMENT ef20030961_8k_htm.xml XML 4056
Mailing Address 2855 GAZELLE COURT CARLSBAD CA 92010
Business Address 2855 GAZELLE COURT CARLSBAD CA 92010 7609319200
IONIS PHARMACEUTICALS INC (Filer) CIK: 0000874015 (see all company filings)

EIN.: 330336973 | State of Incorp.: CA | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-19125 | Film No.: 241033238
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)